Drugmakers Agree to Halve Prices to Secure Access to China
Drugmakers Agree to Halve Prices to Secure Access to China Bloomberg 12/28/2020 Bloomberg News © Bloomberg Capsules sit in a sample container at AstraZeneca Plc's new Biologics factory in Sodertalje, Sweden, on Thursday, April 11, 2019. AstraZeneca raised its annual sales forecast, helped by demand for the U.K. drugmaker's roster of new cancer drugs. (Bloomberg) -- Drugmakers from AstraZeneca Plc and GlaxoSmithKline Plc to BeiGene Ltd. agreed to cut prices on some of their newest drugs in China by an average of 51% in order to be covered by the country’s national insura...
Source: msn.com